Hair Loss and Steroids: DHT, Risk and Prevention

The mechanism: DHT, 5-alpha-reductase and the hair follicle

Dihydrotestosterone (DHT) is the most androgenic metabolite of testosterone. It is produced locally in certain tissues — skin, scalp, prostate — by the enzyme 5-alpha-reductase, which converts testosterone into DHT. It is DHT, not testosterone itself, that preferentially binds the androgen receptors of scalp follicles in the temples and crown ^[1].

In genetically predisposed users, DHT binding to the follicle's androgen receptor sets off a miniaturization process: with every growth cycle, the follicle produces a finer, shorter hair until it stops producing one at all. That is male pattern baldness (MPB) — the most common form of male hair loss. On cycle, exogenous androgens amplify the process ^{[3] [5]}.

Evaluating your own predisposition

Before a cycle, an honest baseline check is worth the effort. The best predictor remains direct observation — of the men in your family (father, uncles, maternal grandfather) and of your own scalp at different ages.

Signals to look at

• Family history: a father or uncles who balded early is a strong indicator, though not an absolute one.
• Frontal hairline: are the temples progressively receding? Is the crown thinning in direct light?
• Comb test: regular short, thin, miniaturized hairs coming out?
• Trichogram or dermatologist consult: a specialist visit settles the question objectively (ratio of anagen to telogen hairs, miniaturization signs).

Risk does not break down into clean percentages. But a user already thinning at 25, or one with a heavily affected family, should treat hair loss as a real probability on any cycle that includes high-DHT compounds — and plan accordingly.

The compounds hardest on hair

Hair-loss potential is not the same across the board. Four families stand out ^{[4] [5]}.

Three compounds are notoriously the worst for hair: trenbolone (tren) (which on top of everything is not blocked by finasteride), Masteron and Winstrol. For a predisposed user, these compounds either get avoided or get run with eyes open, accepting the hair cost as an explicit trade-off.

Finasteride: useful, with serious limits

Finasteride is a 5-alpha-reductase inhibitor. At 1 mg/day (Propecia), it cuts serum DHT roughly 70%, which slows hair loss in most predisposed users under natural conditions ^{[1] [2]}. On cycle, its usefulness is real but limited — and it comes with its own questions worth thinking through.

What finasteride blocks — and what it does not

• It blocks the testosterone → DHT conversion (by reducing 5-alpha-reductase activity).
• It is therefore useful when hair loss comes from testosterone itself.
• It is useless against compounds that are already DHT derivatives (Masteron, Winstrol, primobolan) — their structure bypasses the enzyme ^[4].
• It is useless against trenbolone (androgenic action that does not route through DHT).

The post-finasteride side-effect debate

Finasteride can cause sexual side effects (lowered libido, erectile dysfunction) and neuropsychiatric ones (low mood) in a minority of users. Post-finasteride syndrome (PFS) — the persistence of those effects after stopping the drug — has produced strong user testimony and a more cautious literature, without a definitive medical consensus on its real incidence. For most users the drug is well tolerated, but the individual risk is not zero. The Tressless community has documented this in detail.

Topical treatments and alternatives

Topical options act locally on the scalp without touching systemic DHT metabolism. They are compatible with a cycle and add no hormonal interactions.

Topical minoxidil

Minoxidil 5% as solution or foam, applied twice daily to the affected zones, increases local blood flow and extends the anagen (growth) phase of the follicles. Efficacy is well established, on the condition of continuous use — stopping erases the gains over 3 to 6 months. It is the reference topical tool.

Topical finasteride

Topical finasteride (compounded preparation or newer commercial products) aims to block 5-alpha-reductase at the scalp only, limiting systemic exposure and therefore the potential sexual side effects. Studies are still limited but promising; in practice it is an interesting middle-ground option for users who want to limit PFS risk.

Other options on the table

• Ketoconazole shampoo (Nizoral) 2 to 3 times a week: modest local anti-androgenic effect.
• RU58841 topical: an experimental androgen receptor blocker used at the scalp only, popular on r/tressless but unapproved, unregulated, and with no long-term safety data — proceed with eyes open.
• Microneedling (dermarolling): a stimulation effect, sometimes used alongside minoxidil.
• Hair transplant: surgical option for established baldness, best considered off-cycle.
• Acceptance and shaving: a non-medical option, perfectly valid and increasingly normalized.

The personal trade-off: hair risk vs gains

For a strongly predisposed user, the honest question is: 'am I willing to lose my hair faster in exchange for this level of gains?' There is no universal right answer, but a few concrete principles help.

• Keep testosterone doses contained and prefer compounds with a low DHT-hair profile (nandrolone instead of Masteron on a cut, for instance).
• Avoid the hair-killers if predisposition is strong (trenbolone, Masteron, Winstrol).
• Stabilize a minoxidil routine well before starting the cycle (minoxidil takes 3 to 6 months to show its full effect).
• Get a dermatology check before the cycle: objective baseline lets you compare honestly afterwards.
• Accept that some compounds — trenbolone in particular — almost always cost something on the hair front long term, with or without protection.

Frequently asked questions